TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CytoDyn ( (CYDY) ) has provided an announcement.
On November 23, 2025, CytoDyn Inc. reached an agreement in principle to settle a securities class action lawsuit in the United States District Court for the Western District of Washington. The settlement involves a payment of $500,000 in cash and 49 million shares of common stock to the plaintiffs, contingent upon final documentation and court approval. The agreement does not imply any admission of fault by CytoDyn, and if not finalized, the company plans to defend itself vigorously. The unresolved litigation could potentially impact CytoDyn’s financial condition and operations.
More about CytoDyn
Average Trading Volume: 2,045,931
Technical Sentiment Signal: Buy
Current Market Cap: $414.4M
Find detailed analytics on CYDY stock on TipRanks’ Stock Analysis page.